DEXCOM INC is 20.1x more valuable than AtriCure, Inc. by market capitalization ($28.97 B vs $1.44 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATRC | DXCM |
|---|---|---|
| Market cap | $1.44 B | $28.97 B |
| US-listed rank | #2374 | #474 |
| Revenue (latest FY) | $534.53M | $4.66B |
| Net income (latest FY) | -$11.45M | $836.30M |
| Net margin | -2.1% | 17.9% |
| P/E (trailing FY) | - | 34.6 |
| SEC filings | 1,531 | 2,566 |
DEXCOM INC is 20.1x more valuable than AtriCure, Inc. by market capitalization ($28.97 B vs $1.44 B).
In their latest fiscal years, AtriCure, Inc. reported $534.53M in revenue while DEXCOM INC reported $4.66B.
Full pages: AtriCure, Inc. and DEXCOM INC, or browse the full rankings.